BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23016773)

  • 21. Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China.
    Zhang J; Yang D; Cui X; Liu G; Cui Z; Wang C; Piao H
    Front Cell Infect Microbiol; 2022; 12():935071. PubMed ID: 36105144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Performance of p16
    Song F; Du H; Xiao A; Wang C; Huang X; Yan P; Liu Z; Qu X; Belinson JL; Wu R
    Cancer Manag Res; 2020; 12():9067-9075. PubMed ID: 33061601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination.
    Grimes DR; Corry EMA; Malagón T; O'Riain C; Franco EL; Brennan DJ
    JAMA Netw Open; 2021 Jun; 4(6):e2115321. PubMed ID: 34190993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of cervical cancer screening and triage strategies among women living with HIV in China.
    Duan R; Zhao X; Zhang H; Xu X; Huang L; Wu A; Li L; Qiao Y; Zhao F
    Cancer Med; 2021 Sep; 10(17):6078-6088. PubMed ID: 34342174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.
    Schmitz M; Eichelkraut K; Schmidt D; Zeiser I; Hilal Z; Tettenborn Z; Hansel A; Ikenberg H
    BMC Cancer; 2018 Dec; 18(1):1197. PubMed ID: 30509219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand.
    Sangrajrang S; Laowahutanont P; Wongsena M; Muwonge R; Karalak A; Imsamran W; Senkomago V; Sankaranarayanan R
    Papillomavirus Res; 2017 Jun; 3():30-35. PubMed ID: 28720454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The problem of false-positive human papillomavirus DNA tests in cervical screening.
    Rebolj M; Pribac I; Frederiksen ME; Lynge E
    Curr Pharm Des; 2013; 19(8):1439-49. PubMed ID: 23016777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis.
    Kelly H; Jaafar I; Chung M; Michelow P; Greene S; Strickler H; Xie X; Schiffman M; Broutet N; Mayaud P; Dalal S; Arbyn M; de Sanjosé S
    EClinicalMedicine; 2022 Nov; 53():101645. PubMed ID: 36187721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan.
    Tshomo U; Franceschi S; Tshokey T; Tobgay T; Baussano I; Tenet V; Heideman DAM; Snijders PJF; Clifford GM
    Oncotarget; 2017 Sep; 8(42):72438-72446. PubMed ID: 29069800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Can a High-Performance Screening Strategy Be Determined for Cervical Cancer Prevention? Evidence From a Hierarchical Clustering Analysis of a Multicentric Clinical Study.
    Bao H; Zhang X; Bi H; Zhao Y; Fang L; Wang H; Wang L
    Front Oncol; 2022; 12():816789. PubMed ID: 35155253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A feasibility study on cervical screening in non-attenders invited to undergo HPV self-sampling with cytology triage versus repeat invitation for cytology screening in Hokkaido].
    Taniguchi S; Sakuragi N; Hanley SJB; Tsukiyama K; Fujita H; Sagae S; Kajii N; Watari H; Tamakoshi A
    Nihon Koshu Eisei Zasshi; 2021 Dec; 68(11):719-727. PubMed ID: 34373426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China.
    Ruan G; Song Y; Dong B; Mao X; Lin F; Kang Y; Xu S; Chen X; Wu Q; Sun P
    Cancer Manag Res; 2018; 10():3227-3235. PubMed ID: 30233239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting.
    Hussein T; Desai M; Tomlinson A; Kitchener HC
    BJOG; 2005 Nov; 112(11):1542-6. PubMed ID: 16225576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting.
    McAdam M; Sakita J; Tarivonda L; Pang J; Frazer IH
    PLoS One; 2010 Oct; 5(10):e13266. PubMed ID: 20949059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-type HPV mRNA versus 14-type HPV DNA test: test performance, over-diagnosis and overtreatment in triage of women with minor cervical lesions.
    Westre B; Giske A; Guttormsen H; Sørbye SW; Skjeldestad FE
    BMC Clin Pathol; 2016; 16():9. PubMed ID: 27279798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of p16/Ki-67 and p16/mcm2 on the detection of cervical intraepithelial neoplasia: a prospective study from China.
    Liao GD; Kang LN; Li J; Zeng X; Chen W; Xi MR
    Int J Clin Exp Pathol; 2018; 11(8):4101-4108. PubMed ID: 31949801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions.
    Xie H; Norman I; Hjerpe A; Vladic T; Larsson C; Lui WO; Östensson E; Andersson S
    Oncol Lett; 2017 May; 13(5):3586-3598. PubMed ID: 28529583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China.
    Dang L; Kong L; Zhao Y; Dai Y; Ma L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Qiao Y; Lang J
    Chin J Cancer Res; 2022 Oct; 34(5):496-509. PubMed ID: 36398123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study.
    Thomsen LT; Kjær SK; Munk C; Frederiksen K; Ørnskov D; Waldstrøm M
    Clin Epidemiol; 2020; 12():203-213. PubMed ID: 32110112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high-performance human papillomavirus testing to improve cervical cancer screening in China: a prospective population-based multicentre cohort study.
    Yin J; Zhang S; Li Z; Li Y; Wang H; Zhang X; Pan Q; Chen W; Luo X; Sun X; Zhao F; Qiao Y
    Clin Microbiol Infect; 2024 Apr; ():. PubMed ID: 38599463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.